Company page
Polypeptide Group Ag
Polypeptide Group AG, trading under the ticker PPGN, is a public company based in Switzerland. With a market capitalization of approximately 1.53 billion Swiss francs, the company specializes in the development and production of peptide-based therapeutics. Polypeptide Group AG is committed to delivering high-quality solutions in the pharmaceutical industry.
- Ticker
- PPGN:SIX
- Asset type
- Stock
- Market cap
- $1.53B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- SIX
- Currency
- CHF